The 12th annual G-FINDER report, published by Policy Cures Research at the end of January, is an annual global review of research funding into NTDs and it contains mixed messages.
Total NTD funding increased for the third year in a row. But funding for the six most neglected diseases – including leprosy – fell. Leprosy research funding, at US $10 million, is at the lowest level for seven years. Half the leprosy research funding came from National Institutes for Health (US) and the Indian Council for Medical Research. ILEP Members and LRI contributed 20%.